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ACTIVATED polymorphonuclear leucocytes, which are ac-
cumulated in inflammatory lesions of inflammatory
bowel disease, produce tissue destructive, oxygen de-
rived free radicals and other inflammatory mediators.
The PMN superoxide production elicited by
formyl-methionyl-leucyl-phenylalanine or the comple-
ment split product 5a were compared in IBD and healthy
volunteers. Significantly reduced superoxide production
was found in PMNs from patients with Crohn’s disease as
compared to normal controls, when fMLP or CSa were
used as stimulants (p < 0.001 and p < 0.01, respectively),
whereas no differences were found when ulcerative
colitis patients were compared to normal controls
(p > 0.05). The enhanced oxygen derived free radical pro-
duction previously reported in active IBD, and especially
in CD intestinal lesions, may either be due to an accumu-
lation of productive phagocytes or to a change of the
inflammatory profile of these cells when migrating into
intestinal lesions, possibly due to interaction with other
mediators (e.g. adhesion molecules and interleukins).
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Introduction
Neutrophils and macrophages are prominent in the
inflamed bowel wall of patients with ulcerative colitis
(UC) and Crohn’s disease (CD), and it has been
suggested that these phagocytes play a predominant
role in the progression of tissue damage at inflamma-
tory sites." They produce a diversity of pro-inflamma-
tory mediators, including the reactive oxygen species
superoxide, hydrogen peroxide, hypochlorus acid
and hydroxyl radicals.
Neutrophils and macrophages migrating into the
tissues originate from the circulating pool of these
cells. It has been hypothesized that the cause of
inflammatory bowel disease (IBD) may be related to
an inherent defective function of these circulating
leukocytes, 2,4 even various other factors like adhe-
sion molecules and interleukins also may be im-
portant. It is therefore of interest to study
the function of peripheral leukocytes from patients
with IBD.
In the present study the capacity of circulating
neutrophils from untreated UC and CD patients for
superoxide production in response to challenge
with two physiologically relevant stimuli, N-
formylmethionine- leucyl-phenylalanine (fMLP) and
complement split product 5a (C5a)was measured in
vitro. Pathogenic roles for molecules of the bacterial
cell wall products of N-formyl-methionyl peptides
and of the complement cascade in IBD have earlier
been proposed, but the nature and extent of their
involvement in the immunopathophysiology is still
undefined. 5,6
Materials and Methods
Human PMNs were isolated from the blood of IBD
patients; 21 fulfilling the diagnostic criteria for CD,
20 for UC, and 29 healthy volunteers. None of the
IBD patients or controls were allowed to take any
drugs for the preceding 4 weeks (i.e. all IBD patients
were without specific treatment with 5-aminosalicylic
acid and/or glucocorticoids). Disease activity was
scored according to a semiquantitative scale (0 re-
mission, 1 slight, 2 moderate, and 3 severe).
The blood was drawn into EDTA (10 mM) and
neutrophilic granulocytes (PMNs) were purified ac-
cording to the method of B6yum.
1 Briefly, erythro-
cytes were allowed to sediment in methylcellulose,
the buffy coat leucocytes were washed, using
hypotonic lysis to remove any contaminating eryth-
rocytes, and the mononuclear leucocytes and plate-
lets were separated from the PMNs by gradient cen-
trifugation in Lymphoprep (Nycomed, Oslo, Nor-
way). More than 90% of PMNs were viable after
challenge with activators (fMLP or recombinant hu-
man C5a) (Sigma Chemical Co, MO, USA), as judged
from the Trypan blue exclusion test.
1
1994 Rapid Communications of Oxford Ltd Mediators of Inflammation. Vol 3. 1994 161O. H. Nielsen, D. Berild and L Ahnfelt-Rnne
Superoxide production was measured, spectro-
photometrically by the superoxide dismutase (SOD)
inhibitable reduction of ferricytochrome c. 12 One ml
aliquots of PMNs (2 x 106 cells/ml) suspended in an
NADPH assay buffer (65 mM Na/K-phosphate ac-
cording to Bromberg and Pick13 were transferred to
plastic cuvettes (1 cm light path). The cells were
stimulated for 5 min with either fMLP (2.3 l.tM) or C5a
(1 l.tM) after previous preincubation with the priming
agent cytochalasin B (100 nM, 15 min), and the
production of superoxide was monitored continu-
ously for up to 15 min at 37C. The reduction of
cytochrome C was measured by the absorbance at
550 nm, against a blank cuvette containing a similar
volume of PMNs, cytochrome C, challenger and
superoxide dismutase (300 IU/ml). The maximal
superoxide production per min was then calculated
from the rate of change of absorbance using the
extinction coefficient E550 2.1 x 104/M/cm. All ex-
periments were performed in duplicate.
Ethics: The present study was performed in accord-
ance with the Second Helsinki Declaration, and ap-
proved by the Scientific Ethical Committee of the
Copenhagen County.
Statistics: Non-parametric statistics (medians, ranges
and percentiles) were applied. Unpaired data were
tested by the Mann-Whitney rank sum test and by
the Kruskal-Wallis test which is a one-way analysis
of variance. A significance limit of 0.05 (200 was
used.
Results
Initial concentration-response studies showed that
a maximal superoxide production was achieved with
2.3 x 10-
M fMLP and 10-
M C5a, respectively. When
this concentration of fMLP was used, the cells from
healthy volunteers produced 9.2 (5.0-15.6), UC pa-
tients 8.2 (2.0-14.3) (N.S.) and CD patients 7.4
(3.4-12.1) (p< 0.001) nmol superoxide/min/2 x 10- cells (median value) (Fig. 1A). The corresponding
values obtained with C5a were 7.1 (2.5-15.4), 5.3
(0.1-11.7) (N.S.) and 3.7 (0.2-9.9) (p< 0.01), respec-
tively (Fig. 1B). Superoxide production was signifi-
cantly impaired in the CD PMNs when comparing the
three groups by a one-way variance analysis (p < 0.03
and p < 0.02 for fMLP and C5a, respectively).
When IBD patients were divided in accordance
with their disease, no statistically significant correla-
tion was found (Fig. 2).
Discussion
Formyl peptides, of which fMLP is a major compo-
nent, are the major chemotactic factor produced by
E. coli. 14 FMLP and complement split products like
C5a stimulate PMN aggregation, superoxide produc-
tion, enzyme secretion and chemotaxis.5a5-9 The
PMNs have specific fMLP- and C5a receptors.2,21 In
the present study these challengers were applied
within the physiologically relevant concentration
range.15.
22
The present study shows a significantly diminished
superoxide production for circulating PMNs of CD
patients, and a trend towards an impaired production
by PMNs from UC. This appears difficult to reconcile
with the hypothesis that production of reactive oxy-
gen metabolites such as superoxide, hydroxyl and
hypochlorite contribute to the tissue injury seen in
active IBD. 23 The discrepancy may, however, be
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FIG. 1. Superoxide production from neutrophilic cells stimulated with either
fMLP (A) or C5a (B) (nmol/min/2 x 106 cells) in 29 controls (C), 20 patients
with ulcerative colitis (UC), or 21 patients with Crohn’s disease. Medians
and 25/75 percentiles are given.
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explained by the high number of PMNs present at
inflamed intestinal segments. Further, it is quite pos-
sible that other cell types such as monocytes/
macrophages may also participate in the production
of oxygen-derived free radicals (ODFR) in inflamed
intestinal segments of IBD,24 and that an interplay
with other mediator systems, such as ICAM-1/LFA-1
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FIG. 2. Superoxide production from neutrophilic cells stimulated with either
fMLP (A) or C5a (B) (nmol/min/2 x 106 cells) among 18 inflammatory bowel
disease patients in remission (R), 16 patients with slight (S) and 7 with
moderate (M) disease activity (O UC) (e CD).
and interleukin-8, may change the profile of periph-
eral PMNs when migrating into intestinal lesions. It
can not be excluded that such an activation of PMNs
may result in an enhanced capacity for superoxide
production locally in the intestine.
Earlier reports have demonstrated impaired ODFR
production of PMNs from IBD patients. 25-z7 Thus,
using a luminol dependent chemiluminescence
method, PMNs from CD and UC produced signifi-
cantly lower amounts of ODFR, as compared to
control patients, when stimulated with fMLP. 26
Two other reports have shown diminished
superoxide production from IBD patients stimulated
with PMA, while the production of hydrogen perox-
ide was normal. 25,27 Further, the content of
superoxide dismutase in PMNs, a cytoprotective en-
zyme, was also markedly diminished in both CD and
UC, whereas the concentration of neutrophil
elastase, a neutral protease, was normal. 25
The present study is the first to investigate
superoxide production in IBD patients who did not
take any drugs. 5-aminosalicylic acid (mesalazine)
and glucocorticoids may both influence PMN pro-
duction of ODFR in vivo. 23’28
In a Japanese study on UC, in which all patients
received their normal medication, a significantly
enhanced chemiluminescence was found in a sub-
group with active disease.29 However, the type II
error in that study was considerable, the fMLP con-
centration applied was approximately 20 times
higher than in the present study, and further no
preincubation with cytochalasine B was performed.
Methodological differences may thus explain these
apparent contradictory results.
In conclusion, peripheral PMNs from CD patients
have an impaired capacity to produce superoxide
upon stimulation with fMLP and C5a in vitro. How-
ever, tissue PMNs and macrophages, which were not
evaluated in the present monocellular system, may
possibly be primed by other mediators of inflamma-
tion, such as leukotrienes, interleukins, adhesion
molecules and lipopolysaccharides, to enhance the
production of tissue destructive ODFR as seen in
intestinal lesions of IBD. Further, the high numbers
of phagocytes migrating into the inflamed intestinal
lesions due to intestinal bacterial derived products,
like fMLP and activated complement split products,
may also contribute to the excess production of
ODFR which is believed to be an important mediator
of tissue destruction in IBD.24,3
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